जर्नल ऑफ़ प्लांट जेनेटिक्स एंड ब्रीडिंग

खुला एक्सेस

हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।

ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं

अमूर्त

Current synopsis: The source: cannabinoids

Jill Woodworth

To manage a diagnosis of TSC one must broaden the scope of germ theory. Focusing on individual manifes­tations without overall integration and oversight of all specialists treating requires solid supports and intricate case management overtime to gain any measure of sta­bility, minimize the impact of manifestations and maintain overall health. Quality of life is significantly strained and diminished over time in many cases as support networks become more siloed, with all communication between providers implemented by a caregiver. Medications are prescribed by multiple parties with little long-term over­sight of cumulative side effects and interactions over time. One must become subservient to the healthcare systems inclusive of behavioural and mental health services, as well as educational settings. The assumption that the profes­sionals from whom we are seeking treatment and support know more about the condition and therefore the key to case management is wrangling experts in specialities and seeking to integrate the most progressive research and treatments, all while holding on to intense patient history and respectfully bow to the top-heavy power struc­ture of modern medicine to guide. There is less of a top-heavy power structure and the use of cannabinoid medi­cine requires much patient involvement and education so eventually, it is managed solely by the individual.